ARCHIVES

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

This article is from The Cancer Letter archive.

Vol. 33 No. 18 | May 11, 2007

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: March 1 Deadline For ACS Fellowships; Program Announcements

January 23, 1998

NCAB Member Pollin Organizes Minority Outreach Effort

January 4, 1991

Metastasis Research Is Example Of Progress Under 1971 Cancer Act

May 10, 1991

Upton May Leave NCI Soon, Newell Accepts Post At M.D. Anderson to Head Cancer Prevention

August 17, 1979

NCI CTEP-Approved Trials For the Month of November

November 28, 2014

DRCCA Board Fails To Agree on New Guidelines For Cancer Control Core Grants, Will Try Again

June 25, 1981